As a board, we are not going to diagnose/cure/treat COVID ! But we can input invaluable opinion as to whether or not Lero and CYDY are worthy of the risk associated with a short term play on treating COVID. Most i think are bullish on long term, I/we just read some debate/discuss endlessly about short term market swinging issues. Two family members and one friend have been shaken out by these swings- OTCBB/NASDAQ no matter, still a biotech with NO current earnings, wish i could wake up and its August, endlessly thinking i should buy more, sell then buy when drops etc is exhausting!
Bugeater


What I think is important to keep in mind is that it is irrelevant if CCL5 is the primary target for Covid 19.

""I think what matters for purposes of our investment is whether or not the patients they receive leronlimab in the clinical trials improve and/or survive at a statistically significant higher rate than their placebo counterparts.

If that happens, our investment will be in good shape in the short term (I have no doubt it will be in good shape in the long term)

Read More: https://investorshangout.com/post/newpost/605...z6S6SqiPaB